• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    Foundation Medicine, Inc. (FMI)

    -NasdaqGS
    34.13 Up 1.03(3.11%) Jul 7, 4:00PM EDT
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    FMIPVT1GHDXMYGNIndustry
    Market Cap:1.17BN/A900.17M2.42B294.30M
    Employees:293N/A7521,649149.00
    Qtrly Rev Growth (yoy):0.68N/A0.02-0.020.16
    Revenue (ttm): 68.92MN/A276.86M721.98M76.94M
    Gross Margin (ttm):0.55N/A0.780.810.47
    EBITDA (ttm):-50.09MN/A-18.76M196.10M-383.85K
    Operating Margin (ttm): -0.84N/A-0.090.24-0.08
    Net Income (ttm):-57.02MN/A-26.64M95.12MN/A
    EPS (ttm):-2.02N/A-0.841.25N/A
    P/E (ttm):N/AN/AN/A27.8129.73
    PEG (5 yr expected):N/AN/A-0.161.761.20
    P/S (ttm):16.46N/A3.213.273.92
     
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

     
    News on Direct Competitors 

    Currency in USD.